HACKENSACK, NJ — Champions Oncology, Inc reported today in a filing with the U.S. Securities and Exchange Commission it had raised $8,500 in new funding. Companies file this special form with the U.S. Securities and Exchange Commission in the majority of cases when closing new funding.

Champions Oncology, Inc reported their revenue as between $1 - 5 million within the SEC Filing detailing the transaction. The type of investment being offered was listed as equity (opposed to debt, warrants, or other types of investment options). Champions Oncology, Inc noted they began raising the money on February 8, 2012. As of today, the entire $8,500 offering has been sold to private investors, no remaining investment is being sought at this time.

Digging into Champions Oncology, Inc's fundraising history, Champions Oncology, Inc has filed 4 fundraising documents with the U.S. Securities and Exchange Commission. Their last filing with the SEC on April 4, 2011 noted $9.4M in new investment. Previous to this filing, Champions Oncology, Inc had a $1 fund raise on March 25, 2011.

The SEC Filing can be viewed in its entirety by clicking here: Champions Oncology, Inc Form D SEC Filing.